International Development Grant
Providing Access to COVID-19 Vaccines for Populations in Situations of Vulnerability in the America
Project Number: CA-3-P010068001
Status: Closed
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $50,000,000.00
Start Date: March 30, 2021
End Date: September 04, 2023
Duration: 2.4 years
Project Description
The project aims to improve health and increase protection from COVID-19 for populations in situations of vulnerability in Latin America and the Caribbean. The primary focus of the COVID-19 vaccine-related interventions focuses on those at high-risk for COVID-19 including Venezuelan migrants. Project activities include: (1) Supporting increased surge capacity for vaccinators and public health workers; (2) Supporting the assessment of the cold chain capacity and addressing any identified gaps and other related key supplies for effective distribution; (3) Supporting countries on international shipping and national distribution of vaccine supplies; and (4) Supporting the identification of populations in vulnerable situations such as migrants to ensure equitable access to vaccines and inclusion in vaccination programs in a culturally appropriate gender-sensitive and human rights-based manner.
Expected Results
The expected outcomes for this project include: (1) enhanced effective and equitable delivery of COVID-19 vaccine for women and men within at-risk groups; and (2) increased equitable and timely access and coverage of COVID-19 vaccines for women and men.
Progress & Results Achieved
Results achieved at the end of the project (December 2023) include: (1) supported 35 countries and territories in the Caribbean and Latin America region to develop update and operationalise their national plan for the deployment and use of COVID-19 vaccines following with the Pan-American Health Organization or World Health Organization (WHO); (2) provided and delivered 974 040 COVID-19 vaccines in the Caribbean and Latin American regions; (3) provided and delivered vaccination-related equipment including 3 028 400 syringes over 2 600 refrigerators freezers vaccine carriers or cold boxes 9 cold rooms over 46 000 temperature monitoring devices almost 87 000 ice packs and 332 300 safety boxes; (4) published a report titled “Analysis of COVID-19 vaccination in the Americas Region: Breakdown by sex and age and in selected subpopulations”. This allowed 10 countries to present disaggregated data on COVID-19 vaccination; and (5) strengthened quality assurance process and COVID-19 vaccine deployment plans according to the WHO Emergency Use for 37 countries. This allowed to surpass the original target by 7 countries.
Key Information
Executing Agency:
PAHO - Pan American Health Organization
Reporting Organization:
Global Affairs Canada
Program:
NGM Americas
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Project-type interventions
Collaboration: Bilateral
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Department-Initiated